Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Licitra

Showing results (11-20 of 311) with videos related to

Pageof 32
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Multikinase inhibitors in thyroid cancerLisa Licitra, Laura D Locati
Critical Reviews in Oncology/Hematology|July 6, 2002
Antiemetic therapyLisa Licitra, Silvia Spinazzé, Fausto Roila
The New England Journal of Medicine|March 15, 2008
TP53 mutations in head and neck cancerFederica Perrone, Paolo Bossi, Lisa Licitra
Current Opinion in Oncology|March 16, 2013
Therapeutic strategies in the management of patients with metastatic anaplastic thyroid cancer: review of the current literatureRoberta Granata, Laura Locati, Lisa Licitra
Expert Opinion on Emerging Drugs|October 8, 2013
Emerging tyrosine kinase inhibitors for head and neck cancerPaolo Bossi, Laura Locati, Lisa Licitra
Oral Oncology|November 19, 2015
Individualised quality of life as a measure to guide treatment choices in squamous cell carcinoma of the head and neckLisa Licitra, Ricard Mesía, Ulrich Keilholz
JAMA|December 21, 2017
Benefits and Risks of Machine Learning Decision Support SystemsLisa Licitra, Annalisa Trama, Hykel Hosni
Current Opinion in Otolaryngology & Head and Neck Surgery|February 13, 2018
Immunotherapy for recurrent/metastatic head and neck cancerSalvatore Alfieri, Stefano Cavalieri, Lisa Licitra
British Journal of Cancer|August 12, 2015
Comment on 'Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base'Paolo Bossi, Ester Orlandi, Lisa Licitra
Current Opinion in Otolaryngology & Head and Neck Surgery|February 14, 2012
Oropharyngeal cancer - is it time to change management according to human papilloma virus status?Hisham Mehanna, Oladejo Olaleye, Lisa Licitra
Pageof 32

Showing results (11-20 of 311) with videos related to

Sort By:
Pageof 32
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Multikinase inhibitors in thyroid cancerLisa Licitra, Laura D Locati
Critical Reviews in Oncology/Hematology|July 6, 2002
Antiemetic therapyLisa Licitra, Silvia Spinazzé, Fausto Roila
The New England Journal of Medicine|March 15, 2008
TP53 mutations in head and neck cancerFederica Perrone, Paolo Bossi, Lisa Licitra
Current Opinion in Oncology|March 16, 2013
Therapeutic strategies in the management of patients with metastatic anaplastic thyroid cancer: review of the current literatureRoberta Granata, Laura Locati, Lisa Licitra
Expert Opinion on Emerging Drugs|October 8, 2013
Emerging tyrosine kinase inhibitors for head and neck cancerPaolo Bossi, Laura Locati, Lisa Licitra
Oral Oncology|November 19, 2015
Individualised quality of life as a measure to guide treatment choices in squamous cell carcinoma of the head and neckLisa Licitra, Ricard Mesía, Ulrich Keilholz
JAMA|December 21, 2017
Benefits and Risks of Machine Learning Decision Support SystemsLisa Licitra, Annalisa Trama, Hykel Hosni
Current Opinion in Otolaryngology & Head and Neck Surgery|February 13, 2018
Immunotherapy for recurrent/metastatic head and neck cancerSalvatore Alfieri, Stefano Cavalieri, Lisa Licitra
British Journal of Cancer|August 12, 2015
Comment on 'Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base'Paolo Bossi, Ester Orlandi, Lisa Licitra
Current Opinion in Otolaryngology & Head and Neck Surgery|February 14, 2012
Oropharyngeal cancer - is it time to change management according to human papilloma virus status?Hisham Mehanna, Oladejo Olaleye, Lisa Licitra
Pageof 32